Responsible for driving corporate level strategy development for a Fortune 500 global leader in Healthcare data analytics and pharmaceutical drug development including via M&A. Support harmonization of global & regional Business Unit strategic plans across Technology & Analytics Solutions (TAS), Real World Solutions (RWS), and Research & Development Solutions (R&DS).

Drive organic and inorganic growth initiativesResponsible for M&A, Strategy setting, and strategic execution

Responsible for leading global strategy and corporate development (including M&A) for Q Squared Solutions, which includes Central laboratories technology, bioanalytical and Genomics clinical trial services.

Director of Global Corporate Strategy for multiple business units including clinical monitoring, patient recruitment, early clinical development and global labs. Drive with senior leadership the identification and assignment of key strategic initiatives

Lead and executed the company’s strategic plan as it related to mergers, acquisitions and joint partnerships, responsible for a combined $200M in assets.

As the co-founder, chief executive officer and chief technology officer, I raised private-equity financing and created and executed a business plan for an innovative mobile health technology that leverage artificial intelligence (AI) engine to help patients manage chronic conditions. Through lean product-development cycles and high user satisfaction, as well as aggressive concept-to-launch project timelines, we were able to generate revenue with 5 months of inception by signing major clients covering 10,000 users (including a major NC payor). The company ultimately employed a team of over 20 software developers, marketing and sales associates.

Lead acquisition activities and ultimate sale of business to Smith & Nephew.

As the founder of this neuro-technology company, I created and executed a business plan for neurology-based medical device products, collaborating with the National Institute of Health (NIH), Harvard Neurology and MIT engineering to commercial a medical device within the constraints of a highly regulated industry.